HCA Earnings

HCA reported its earnings on 2026-01-27, showcasing a revenue of 19.51B against an estimate of 19.68B, resulting in a -0.85% surprise. The EPS was 8.01, surpassing the expected 7.36 by 8.83%. The stock experienced a 7.08% price change on the earnings day and a 3.36% change over the next five days, reflecting market reactions to the results.

Following HCA's earnings announcement on 2026-01-27, the stock price moved by 7.08% on the day of the release. Over the subsequent five days, it saw a 3.36% change. Historically, HCA's stock price tends to shift by an average of 1.07% in the 10 days leading up to earnings and 4.07% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate HCA's annual revenue to reach 19.17B, while the EPS is projected at 7.17. These estimates reflect recent revisions, with revenue estimates revised upward by 0.06% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HCA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.06%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HCA's stock price typically moves by 1.07% in the 10 days before its earnings and 4.07% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 7.17 and revenue of 19.17B.

The earnings call highlights strong financial performance, including a 20% YoY EPS increase and improved EBITDA margins. Share repurchases and dividends indicate shareholder value focus. Despite challenges like Medicaid volumes flattening and increased professional fees, the company maintains strong guidance and operational leverage. The Q&A session reveals management's confidence in handling potential risks, with no major negative surprises. The overall sentiment is positive, driven by robust earnings, strategic investments in AI and technology, and a balanced capital allocation strategy.